Purple Biotech (PPBT)

NASDAQ
Currency in USD
3.680
-0.100(-2.65%)
Real-time Data
PPBT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
3.6803.870
52 wk Range
2.00020.600
Key Statistics
Edit
Prev. Close
3.78
Open
3.682
Day's Range
3.68-3.87
52 wk Range
2-20.6
Volume
26.96K
Average Volume (3m)
939.3K
1-Year Change
-72.61%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PPBT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
33.000
Upside
+796.74%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Purple Biotech ADR Company Profile

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel.

Compare PPBT to Peers and Sector

Metrics to compare
PPBT
Peers
Sector
Relationship
P/E Ratio
−0.9x−1.2x−0.6x
PEG Ratio
−0.020.000.00
Price/Book
0.3x0.6x2.6x
Price / LTM Sales
-1.8x3.1x
Upside (Analyst Target)
-465.8%55.4%
Fair Value Upside
Unlock9.4%10.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 33.000

(+796.74% Upside)

Earnings

Latest Release
Nov 5, 2024
EPS / Forecast
-- / -0.07
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Purple Biotech ADR (PPBT) Stock Price Today?

The Purple Biotech ADR stock price today is 3.68.

What Stock Exchange Does Purple Biotech ADR Trade On?

Purple Biotech ADR is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Purple Biotech ADR?

The stock symbol for Purple Biotech ADR is "PPBT."

What Is the Purple Biotech ADR Market Cap?

As of today, Purple Biotech ADR market cap is 10.24M.

What is Purple Biotech ADR Earnings Per Share?

The Purple Biotech ADR EPS is -0.053.

From a Technical Analysis Perspective, Is PPBT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.